These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 22374176)

  • 61. Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus.
    Rosa CM; Gimenes R; Campos DH; Guirado GN; Gimenes C; Fernandes AA; Cicogna AC; Queiroz RM; Falcão-Pires I; Miranda-Silva D; Rodrigues P; Laurindo FR; Fernandes DC; Correa CR; Okoshi MP; Okoshi K
    Cardiovasc Diabetol; 2016 Sep; 15(1):126. PubMed ID: 27585437
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice.
    Xue M; Li T; Wang Y; Chang Y; Cheng Y; Lu Y; Liu X; Xu L; Li X; Yu X; Sun B; Chen L
    Clin Sci (Lond); 2019 Aug; 133(15):1705-1720. PubMed ID: 31337673
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Galectin-3 mediates cardiac remodeling caused by impaired glucose and lipid metabolism through inhibiting two pathways of activating Akt.
    Sun Z; Zhang L; Li L; Shao C; Liu J; Zhou M; Wang Z
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H364-H380. PubMed ID: 33275526
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat.
    Tate M; Deo M; Cao AH; Hood SG; Huynh K; Kiriazis H; Du XJ; Julius TL; Figtree GA; Dusting GJ; Kaye DM; Ritchie RH
    Diab Vasc Dis Res; 2017 Sep; 14(5):423-433. PubMed ID: 28565941
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy.
    Zhang L; Ding WY; Wang ZH; Tang MX; Wang F; Li Y; Zhong M; Zhang Y; Zhang W
    J Transl Med; 2016 Apr; 14(1):109. PubMed ID: 27121077
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oxytocin treatment prevents the cardiomyopathy observed in obese diabetic male db/db mice.
    Plante E; Menaouar A; Danalache BA; Yip D; Broderick TL; Chiasson JL; Jankowski M; Gutkowska J
    Endocrinology; 2015 Apr; 156(4):1416-28. PubMed ID: 25562615
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hypertension is a conditional factor for the development of cardiac hypertrophy in type 2 diabetic mice.
    van Bilsen M; Daniels A; Brouwers O; Janssen BJ; Derks WJ; Brouns AE; Munts C; Schalkwijk CG; van der Vusse GJ; van Nieuwenhoven FA
    PLoS One; 2014; 9(1):e85078. PubMed ID: 24416343
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
    Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
    Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vascular endothelial growth factor inhibition by dRK6 causes endothelial apoptosis, fibrosis, and inflammation in the heart via the Akt/eNOS axis in db/db mice.
    Park CW; Kim HW; Lim JH; Yoo KD; Chung S; Shin SJ; Chung HW; Lee SJ; Chae CB; Kim YS; Chang YS
    Diabetes; 2009 Nov; 58(11):2666-76. PubMed ID: 19675133
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Forskolin Protected against Streptozotocin-Induced Diabetic Cardiomyopathy via Inhibition of Oxidative Stress and Cardiac Fibrosis in Mice.
    Zhang X; Ke PX; Yuan X; Zhang GP; Chen WL; Zhang GS
    Biomed Res Int; 2021; 2021():8881843. PubMed ID: 33564685
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Zinc Prevents the Development of Diabetic Cardiomyopathy in db/db Mice.
    Wang S; Wang B; Wang Y; Tong Q; Liu Q; Sun J; Zheng Y; Cai L
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272348
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Earlier onset of diabesity-Induced adverse cardiac remodeling in female compared to male mice.
    Bowden MA; Tesch GH; Julius TL; Rosli S; Love JE; Ritchie RH
    Obesity (Silver Spring); 2015 Jun; 23(6):1166-77. PubMed ID: 25959739
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.
    Guleria RS; Singh AB; Nizamutdinova IT; Souslova T; Mohammad AA; Kendall JA; Baker KM; Pan J
    J Mol Cell Cardiol; 2013 Apr; 57():106-18. PubMed ID: 23395853
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy.
    Ni R; Cao T; Xiong S; Ma J; Fan GC; Lacefield JC; Lu Y; Le Tissier S; Peng T
    Free Radic Biol Med; 2016 Jan; 90():12-23. PubMed ID: 26577173
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10.
    Zhang YP; Song CY; Yuan Y; Eber A; Rodriguez Y; Levitt RC; Takacs P; Yang Z; Goldberg R; Candiotti KA
    Neurobiol Dis; 2013 Oct; 58():169-78. PubMed ID: 23684663
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Shengmai San Alleviates Diabetic Cardiomyopathy Through Improvement of Mitochondrial Lipid Metabolic Disorder.
    Tian J; Tang W; Xu M; Zhang C; Zhao P; Cao T; Shan X; Lu R; Guo W
    Cell Physiol Biochem; 2018; 50(5):1726-1739. PubMed ID: 30384366
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impaired cardiac functional reserve in type 2 diabetic db/db mice is associated with metabolic, but not structural, remodelling.
    Daniels A; van Bilsen M; Janssen BJ; Brouns AE; Cleutjens JP; Roemen TH; Schaart G; van der Velden J; van der Vusse GJ; van Nieuwenhoven FA
    Acta Physiol (Oxf); 2010 Sep; 200(1):11-22. PubMed ID: 20175764
    [TBL] [Abstract][Full Text] [Related]  

  • 78. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
    Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
    Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.
    Huynh K; McMullen JR; Julius TL; Tan JW; Love JE; Cemerlang N; Kiriazis H; Du XJ; Ritchie RH
    Diabetes; 2010 Jun; 59(6):1512-20. PubMed ID: 20215428
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: a study in humans and rats.
    Despa S; Margulies KB; Chen L; Knowlton AA; Havel PJ; Taegtmeyer H; Bers DM; Despa F
    Circ Res; 2012 Feb; 110(4):598-608. PubMed ID: 22275486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.